)
AlzChem Group (ACT) investor relations material
AlzChem Group H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
Achieved consolidated sales of EUR 562.1 million in 2025, near the forecasted EUR 580 million, with 2% revenue growth and 11% EBITDA growth year-over-year, outperforming a challenging European chemical environment.
Group EBITDA rose 11% to EUR 116.5 million, exceeding guidance, with a record EBITDA margin of 20.7%.
Net income increased 17% to EUR 64 million, supporting a proposed 17% dividend increase to EUR 2.10 per share.
Specialty chemicals segment drove growth, especially in human nutrition and defense, offsetting declines in basic/intermediate chemicals.
Major investments in creatine and nitroguanidine capacity expansions, including a EUR 120 million creatine plant, are set to fuel future growth.
Financial highlights
Sales increased by EUR 8 million year-over-year to EUR 562.1 million, with strongest growth in the U.S. and Europe.
EBITDA grew by EUR 11 million to EUR 116.5 million, outpacing sales growth due to higher-margin specialty products.
Net income reached EUR 64 million, up 18% year-over-year; EPS increased 18.3% to EUR 6.28.
Operating cash flow rose 30% to EUR 137 million, benefiting from EUR 60 million in customer grants and higher working capital.
Maintained a positive net cash position of EUR 31 million at year-end; cash and cash equivalents increased to EUR 71.7 million.
Outlook and guidance
2026 sales expected to reach EUR 600 million (+7%), with EBITDA forecast at EUR 126 million (+8%).
Growth to be driven organically, especially by specialty chemicals, human nutrition, and defense.
Major capacity expansions in creatine and nitroguanidine to support double-digit growth in 2027.
Maintenance shutdown of a carbide furnace in H1 2026 will impact EBITDA by approx. EUR 15 million.
Free cash flow expected to be around zero in 2026 due to high CapEx and customer prepayments.
Next AlzChem Group earnings date
Next AlzChem Group earnings date
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
I can't remember the last time an app had such a positive impact on my investment process.
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage
)
)